Pneumoconiosis clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
FAPI PET for Lung Fibrosis
open to eligible people ages 18 years and up
This is a prospective exploratory biodistribution study in patients with interstitial lung disease (ILD). The purpose of this research study is to determine where and to which degree the FAPI tracer (68Ga-FAPI-46) accumulates in normal and fibrotic…
at UCLA
Our lead scientists for Pneumoconiosis research studies include Jeremie Calais.
Last updated: